The Kensey Nash board of directors unanimously recommended the offer for DSM to acquire all outstanding shares of the company. The agreed price represents a premium of 33 percent to Kensey Nash’s closing share price yesterday.
The acquisition with strengthen DSM’s biomedical business.
More Articles on Orthopedic Devices:
Wright Medical Group Sales Fall 6% After Distributor Transitions
Exactech Hip & Knee Revenue Up, Spine Drops 13%
DJO Global Net Sales Jump 11.7%
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.